1. Ahr is a zika virus host factor and candidate for antiviral-therapy. Giovanonni F, Bosch IO, Polonio CL, Torti MF, Wheeler MA, Li Z, Peron JPS, Garcia CC, Quintana FJ. 2020 Nat Neurosci. 2020 Aug;23(8):939-951.
2. COVID-19 Pandemic and Dysbiosis: Can the Ivermectin Hysteria Lead to an Increase of Autoimmune Neuroinflammatory Diseases? Peron JPS, Nakaya HI, Schlindwein MAM, Gonçalves MVM. Crit Rev Immunol. 2020;40(6):537-542.
3. Prodrugs as new therapy against Chagas disease: in vivo synergy between Trypanosoma cruzi proline racemase inhibitors and benznidazole. Dias de Melo, G.; Coatnoan, N., Gouault, N., Cupif, JF, Renault, J., Cosson, A., Monet, D, Uriac, P., Blondel, A., Minoprio, P. (submitted 2020)
4. Alternative resources during SARS-CoV-2 outbreak: Production and validation of 3D- produced nasopharyngeal swabs to collect clinical samples (THEIJID-D-21-01605). submitted IJDI – International Journal of Infectious Disease (under review)
5. Network vaccinology. Creighton R, Schuch V, Urbanski AH, Giddaluru J, Costa-Martins AG, Nakaya HI. Semin Immunol. 2020 Aug;50:101420.
6. Immature neutrophil signature associated with the sexual dimorphism of systemic juvenile idiopathic arthritis. Prada-Medina CA, Peron JPS, Nakaya HI. J Leukoc Biol. 2020 Oct;108(4):1319-1327. Epub 2020 Aug 13.
7. ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19. Pinto BGG, Oliveira AER, Singh Y, Jimenez L, Gonçalves ANA, Ogava RLT, Creighton R, Schatzmann Peron JP, Nakaya HI. J Infect Dis. 2020 Jul 23;222(4):556-563.
8. Molecular alterations in the extracellular matrix in the brains of newborns with congenital Zika syndrome. Aguiar RS, Pohl F, Morais GL, Nogueira FCS, Carvalho JB, Guida L, Arge LWP, Melo A, Moreira MEL, Cunha DP, Gomes L, Portari EA, Velasquez E, Melani RD, Pezzuto P, de Castro FL, Geddes VEV, Gerber AL, Azevedo GS, Schamber-Reis BL, Gonçalves AL, Junqueira-de-Azevedo I, Nishiyama MY Jr, Ho PL, Schanoski AS, Schuch V, Tanuri A, Chimelli L, Vasconcelos ZFM, Domont GB, Vasconcelos ATR, Nakaya HI. Sci Signal. 2020 Jun 9;13(635):eaay6736.
9. Susceptibility of the Elderly to SARS-CoV-2 Infection. Peron JPS, Nakaya H.: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE). Clinics (Sao Paulo). 2020;75:e1912. doi: 10.6061/clinics/2020/e1912. Epub 2020
10. Drug repositioning for psychiatric and neurological disorders through a network medicine approach. Lüscher Dias T, Schuch V, Beltrão-Braga PCB, Martins-de-Souza D, Brentani HP, Franco GR, Nakaya HI. Transl Psychiatry. 2020 May 12;10(1):141
11. Methods for predicting vaccine immunogenicity and reactogenicity. Gonzalez-Dias P, Lee EK, Sorgi S, de Lima DS, Urbanski AH, Silveira EL, Nakaya HI. Hum Vaccin Immunother. 2020;16(2):269-276.
12. Colorimetric RT-LAMP SARS-CoV-2 diagnostic sensitivity relies on color interpretation and viral load. M.A. Aoki, B. de Oliveira Coelho, L.G. Bentim Góes, P. Minoprio, E.L. Durigon, L.G. Morello, F. Klerynton Marchini, I.N. Riediger, M.C. Debur, H.I. Nakaya & Lucas Blanes. https://www.nature.com/articles/s41598-021-88506-y
13. Large-scale assessment of human mobility during COVID-19 outbreak. Lucas Queiroz, José Luciano Melo, André Ferraz, Gabriel Barboza, Alysson H. Urbanski, André N.A.Gonçalves, Sergio Oliva, Helder I. Nakaya. OSFPreprints. 10.31219/osf.io/nqxrd, 2020.